Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q3 2021 · 10-Q
Revenue$65.90M$65.90M+10.0% vs Q3 2020 Net Income$7.61M$7.61M+11.3% vs Q3 2020 EPS Diluted$0.38$0.38+11.8% vs Q3 2020 Gross Profit$19,623,000+10.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived$6,438,000+50.3% Free Cash Flowderived$5,783,000+101.3% Margins · derivedGross margin29.8%+0.2 pt vs Q3 2020
Operating margin14.1%+0.9 pt vs Q3 2020
Net margin11.6%+0.1 pt vs Q3 2020
ended Dec 31, 2020 · filed Jan 26, 2021 · 26 d after period end